<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: A New Breed of Pharmaceutical Manufacturing</title>
	<atom:link href="http://blog.pharmtech.com/2009/05/08/a-new-breed-of-pharmaceutical-manufacturing/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2009/05/08/a-new-breed-of-pharmaceutical-manufacturing/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Tue, 07 Feb 2012 17:25:13 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Steve</title>
		<link>http://blog.pharmtech.com/2009/05/08/a-new-breed-of-pharmaceutical-manufacturing/comment-page-1/#comment-13508</link>
		<dc:creator>Steve</dc:creator>
		<pubDate>Fri, 08 May 2009 16:58:35 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=1248#comment-13508</guid>
		<description>Here&#039;s the &lt;a href=&quot;http://v3.espacenet.com/publicationDetails/description;jsessionid=4B761921E14EBBDEB661EAED866444B8.espacenet_levelx_prod_1?CC=WO&amp;NR=2007001264A2&amp;KC=A2&amp;FT=D&amp;date=20070104&amp;DB=EPODOC&amp;locale=en_V3&quot; rel=&quot;nofollow&quot;&gt;Biodefense Patent&lt;/a&gt; for GTC BIOTHERAPEUTICS -

METHOD OF MAKING RECOMBINANT HUMAN ANTIBODIES FOR USE IN BIOSENSOR TECHNOLOGY   
</description>
		<content:encoded><![CDATA[<p>Here&#8217;s the <a href="http://v3.espacenet.com/publicationDetails/description;jsessionid=4B761921E14EBBDEB661EAED866444B8.espacenet_levelx_prod_1?CC=WO&amp;NR=2007001264A2&amp;KC=A2&amp;FT=D&amp;date=20070104&amp;DB=EPODOC&amp;locale=en_V3" rel="nofollow">Biodefense Patent</a> for GTC BIOTHERAPEUTICS -</p>
<p>METHOD OF MAKING RECOMBINANT HUMAN ANTIBODIES FOR USE IN BIOSENSOR TECHNOLOGY</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Steve</title>
		<link>http://blog.pharmtech.com/2009/05/08/a-new-breed-of-pharmaceutical-manufacturing/comment-page-1/#comment-13507</link>
		<dc:creator>Steve</dc:creator>
		<pubDate>Fri, 08 May 2009 16:48:23 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=1248#comment-13507</guid>
		<description>You are 100% correct. 

What is NOT known is that GTC Biotherapeutics has a Biodefense Patent that can protect this country from all known chemical &amp; bilogical agents.

However, right now the French Government might be the new owner of this entire technology as of June 1. Doesn&#039;t the U.S. Government realize how valuable this is??</description>
		<content:encoded><![CDATA[<p>You are 100% correct. </p>
<p>What is NOT known is that GTC Biotherapeutics has a Biodefense Patent that can protect this country from all known chemical &amp; bilogical agents.</p>
<p>However, right now the French Government might be the new owner of this entire technology as of June 1. Doesn&#8217;t the U.S. Government realize how valuable this is??</p>
]]></content:encoded>
	</item>
</channel>
</rss>

